Incivo
Two hepatitis C drugs win Prix Galien
September 28, 2012Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien
Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …
Two new hep C pills recommended by NICE
April 25, 2012Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C
NICE has given its final recommendation for two new hepatitis C pills in an expedited review. Janssen’s Incivo (telaprevir) and …
NICE recommends Incivo for hepatitis C
March 16, 2012Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir
NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …
NICE recommends Victrelis in speedy review
March 9, 2012Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis
NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review. In its final …
Janssen launches hep C support programme
February 27, 2012Medical Communications, Sales and Marketing BUPA, Copegas, Incivo, Janssen, Pegasys, hep C
Janssen has launched a hepatitis C support programme for patients in the UK to help with medicine adherence and healthy …
Boehringer hails hepatitis C candidate
November 9, 2011Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C
Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …
Janssen launches Incivo in the UK
October 10, 2011Sales and Marketing Incivek, Incivo
Janssen’s new hepatitis C treatment Incivo has been launched in the UK, one of two new drugs set to advance …
J&J’s hep C drug Incivo approved in Europe
September 22, 2011Sales and Marketing Incivek, Incivo, Victrelis
J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …
Hepatitis C rivals go head to head
July 19, 2011Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
